jianxing he, MD
The First Affiliated Hospital of Guangzhou Medical University
7
4
1
N/A
0
9
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Caicun Zhou, MD
Shanghai Pulmonary Hospital, Shanghai, China
Shared therapeutic areas:
Worked with same sponsors:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Meral Boşnak Güçlü, Prof. Dr.
Gazi University
Shared therapeutic areas:
Konrad E Bloch, MD
University Hospital, Zürich
Shared therapeutic areas:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Worked with same sponsors:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Marie Carmen Valenza, phD
Universidad de Granada
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
The Efficacy of PD-1 Antibody Sintilimab on Early-stage Multiple Primary Lung Cancer With Ground Glass Density.
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung
A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer
All 7 trials loaded